Overview

This trial is active, not recruiting.

Condition conversion disorder
Treatment rehabilitation
Phase phase 1/phase 2
Sponsor Oslo University Hospital
Collaborator Norwegian School of Sport Sciences
Start date September 2007
End date September 2010
Trial size 60 participants
Trial identifier NCT01422278, 2.2004.164, SSR.2005.1

Summary

Evaluating the effects in functional status after three weeks of cognitive - and behavioural rehabilitation on patients with gait disorder. The patients are followed up as after 1 and 12 months to study if any improvement is still present. The patients are being recruited from neurological units. The intervention is explanation of symptoms, positive reinforcement of normal behaviour and absence reinforcement of dysfunctional behaviour. In addition the study aims at describing typical gait patterns at patients with gait disorder by using biomechanical measurements (EKG).

United States No locations recruiting
Other Countries No locations recruiting

Study Design

Allocation randomized
Endpoint classification efficacy study
Intervention model crossover assignment
Masking single blind (subject)
Primary purpose treatment

Primary Outcomes

Measure
Change in gait patterns
time frame: three weeks

Secondary Outcomes

Measure
Improved life quality
time frame: 12 months

Eligibility Criteria

Male or female participants from 18 years up to 69 years old.

Inclusion Criteria: - To determine the changes in functional status after three weeks of multidisciplinary rehabilitation in patients with conversion walking disorder. Exclusion Criteria: - Essential gait disorders do to conversion symptoms and willingness to participate in either of the two groups with informed consent are required.

Additional Information

Official title Patients With Conversion Gait Disorder - Effect on Treatment and Common Gait Patterns. Randomized Clinical Trial
Description Patients are being recruited from neurological unit/ div and out patients department of SSR and are randomized to treatment or control group. Essential gait disorders do to conversion symptoms and willingness to participate in either of the two groups with informed consent are required.
Trial information was received from ClinicalTrials.gov and was last updated in August 2011.
Information provided to ClinicalTrials.gov by Oslo University Hospital.